162 related articles for article (PubMed ID: 19740539)
1. Deletion of putative intronic control sequences does not alter cell or stage specific expression of Cr2.
Roundy KM; Weis JJ; Weis JH
Mol Immunol; 2009 Dec; 47(2-3):517-25. PubMed ID: 19740539
[TBL] [Abstract][Full Text] [Related]
2. An intronic silencer regulates B lymphocyte cell- and stage-specific expression of the human complement receptor type 2 (CR2, CD21) gene.
Makar KW; Pham CT; Dehoff MH; O'Connor SM; Jacobi SM; Holers VM
J Immunol; 1998 Feb; 160(3):1268-78. PubMed ID: 9570543
[TBL] [Abstract][Full Text] [Related]
3. Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1.
Donius LR; Orlando CM; Weis JJ; Weis JH
Immunobiology; 2014 Jan; 219(1):53-63. PubMed ID: 24012440
[TBL] [Abstract][Full Text] [Related]
4. Yin Yang 1, Oct1, and NFAT-4 form repeating, cyclosporin-sensitive regulatory modules within the murine CD21 intronic control region.
Zabel MD; Wheeler W; Weis JJ; Weis JH
J Immunol; 2002 Apr; 168(7):3341-50. PubMed ID: 11907091
[TBL] [Abstract][Full Text] [Related]
5. Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1.
Donius LR; Handy JM; Weis JJ; Weis JH
J Immunol; 2013 Jul; 191(1):434-47. PubMed ID: 23733878
[TBL] [Abstract][Full Text] [Related]
6. Detection of complement receptors 1 and 2 on mouse splenic B cells using flow cytometry.
Donius LR; Weis JH
Methods Mol Biol; 2014; 1100():305-10. PubMed ID: 24218269
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific expression of the murine CD21 gene depends on accessibility of promoter and intronic elements.
Zabel MD; Byrne BL; Weis JJ; Weis JH
J Immunol; 2000 Oct; 165(8):4437-45. PubMed ID: 11035082
[TBL] [Abstract][Full Text] [Related]
8. Cell-specific regulation of the CD21 gene.
Zabel MD; Weis JH
Int Immunopharmacol; 2001 Mar; 1(3):483-93. PubMed ID: 11367532
[TBL] [Abstract][Full Text] [Related]
9. A new mouse anti-mouse complement receptor type 2 and 1 (CR2/CR1) monoclonal antibody as a tool to study receptor involvement in chronic models of immune responses and disease.
Kulik L; Hewitt FB; Willis VC; Rodriguez R; Tomlinson S; Holers VM
Mol Immunol; 2015 Feb; 63(2):479-88. PubMed ID: 25457881
[TBL] [Abstract][Full Text] [Related]
10. Complement receptors regulate lipopolysaccharide-induced T-cell stimulation.
Kaya Z; Tretter T; Schlichting J; Leuschner F; Afanasyeva M; Katus HA; Rose NR
Immunology; 2005 Apr; 114(4):493-8. PubMed ID: 15804286
[TBL] [Abstract][Full Text] [Related]
11. Evidence for an important interaction between a complement-derived CD21 ligand on follicular dendritic cells and CD21 on B cells in the initiation of IgG responses.
Qin D; Wu J; Carroll MC; Burton GF; Szakal AK; Tew JG
J Immunol; 1998 Nov; 161(9):4549-54. PubMed ID: 9794381
[TBL] [Abstract][Full Text] [Related]
12. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene.
Christensen SM; Martin BK; Tan SS; Weis JH
J Immunol; 1992 Jun; 148(11):3610-7. PubMed ID: 1534100
[TBL] [Abstract][Full Text] [Related]
13. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response.
Fang Y; Xu C; Fu YX; Holers VM; Molina H
J Immunol; 1998 Jun; 160(11):5273-9. PubMed ID: 9605124
[TBL] [Abstract][Full Text] [Related]
14. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
15. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
16. Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice.
Whipple EC; Shanahan RS; Ditto AH; Taylor RP; Lindorfer MA
J Immunol; 2004 Aug; 173(4):2297-306. PubMed ID: 15294942
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the human complement receptor 2 (CR2, CD21) promoter reveals sequences shared with regulatory regions of other developmentally restricted B cell proteins.
Rayhel EJ; Dehoff MH; Holers VM
J Immunol; 1991 Mar; 146(6):2021-6. PubMed ID: 1706386
[TBL] [Abstract][Full Text] [Related]
18. A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation.
Makar KW; Ulgiati D; Hagman J; Holers VM
Int Immunol; 2001 May; 13(5):657-64. PubMed ID: 11312253
[TBL] [Abstract][Full Text] [Related]
19. Multiple transcription factors regulate the inducible expression of the human complement receptor 2 promoter.
Vereshchagina LA; Tolnay M; Tsokos GC
J Immunol; 2001 May; 166(10):6156-63. PubMed ID: 11342636
[TBL] [Abstract][Full Text] [Related]
20. Identification of 5'-regions affecting the expression of the human CR2 gene.
Yang LM; Behrens M; Weis JJ
J Immunol; 1991 Oct; 147(7):2404-10. PubMed ID: 1833454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
